key: cord-0900716-38e0pfre
authors: Howson, Emma L.A.; Kidd, Stephen P.; Armson, Bryony; Goring, Alice; Sawyer, Jason; Cassar, Claire; Cross, David; Lewis, Tom; Hockey, Jess; Rivers, Samantha; Cawthraw, Saira; Banyard, Ashley; Anderson, Paul; Rahou, Sabah; Andreou, Michael; Morant, Nick; Clark, Duncan; Walsh, Charlotte; Laxman, Shailen; Houghton, Rebecca; Slater-Jefferies, Joanne; Costello, Paula; Brown, Ian; Cortes, Nicholas; Godfrey, Keith M.; Fowler, Veronica L.
title: Preliminary optimisation of a simplified sample preparation method to permit direct detection of SARS-CoV-2 within saliva samples using reverse-transcription loop-mediated isothermal amplification (RT-LAMP)
date: 2020-12-20
journal: J Virol Methods
DOI: 10.1016/j.jviromet.2020.114048
sha: 444db5977608d740596ede02ff170a4c496935ff
doc_id: 900716
cord_uid: 38e0pfre

We describe the optimisation of a simplified sample preparation method which permits rapid and direct detection of SARS-CoV-2 RNA within saliva, using reverse-transcription loop-mediated isothermal amplification (RT-LAMP). Treatment of saliva samples prior to RT-LAMP by dilution 1:1 in Mucolyse™, followed by dilution in 10 % (w/v) Chelex© 100 Resin and a 98 °C heat step for 2 min enabled detection of SARS-CoV-2 RNA in positive saliva samples. Using RT-LAMP, SARS-CoV-2 RNA was detected in as little as 05:43 min, with no amplification detected in 3097 real-time reverse transcription PCR (rRT-PCR) negative saliva samples from staff tested within a service evaluation study, or for other respiratory pathogens tested (n = 22). Saliva samples can be collected non-invasively, without the need for skilled staff and can be obtained from both healthcare and home settings. Critically, this approach overcomes the requirement for, and validation of, different swabs and the global bottleneck in obtaining access to extraction robots and reagents to enable molecular testing by rRT-PCR. Such testing opens the possibility of public health approaches for effective intervention during the COVID-19 pandemic through regular SARS-CoV-2 testing at a population scale, combined with isolation and contact tracing.

The COVID-19 pandemic, caused by the SARS-CoV-2 virus, remains a significant burden to global communities, economic activity and healthcare systems. Although studies have reported the development of safe and efficacious vaccines [1] [2] [3] , uncertainty remains as to when these may become generally available. One public health approach that has been advocated for suppression of the COVID-19 pandemic is regular SARS-CoV-2 testing at a population scale, combined with isolation and contact tracing for positive cases 4 . Such an approach requires a rapid, inexpensive diagnostic, based on non-invasive samples that can be collected in both healthcare and non-healthcare settings 5 .

The current diagnostic standard for SARS-CoV-2 is viral RNA detection by real-time reverse transcriptase polymerase chain reaction (rRT-PCR) from nasopharyngeal/oropharyngeal swabs 6 .

However, the procedure for collecting good quality swab samples requires training, potentially exposes the health-care worker to infectious droplets during sample collection, and can be uncomfortable for the patient, especially if undertaken frequently. Critically, supply issues during the pandemic have led to bottlenecks in availability of reagents for molecular assays. Furthermore, the demand for swabs 7 has resulted in laboratories having to undertake frequent validation on different swab types. Exploring alternative sample types and detection methods is an attractive solution. Saliva shows promise as an alternative sample type for diagnostic detection of coronaviruses and has been shown as a matrix where SARS-CoV-2 is found in early infection 8, 9, 10 . Furthermore, collection is straightforward and can be self-collected by drooling into a universal plastic container.

Reverse-Transcription Loop-mediated isothermal AMPlification (RT-LAMP) is a sensitive, isothermal nucleic acid amplification technology 11 which is more resistant to inhibitors than rRT-PCR, enabling simplification and even removal of the sample extraction procedure 12 . LAMP has been applied for detection of a wide range of pathogens in both the veterinary 13, 14 and medical sector 15, 16 . At the height of the SARS-CoV-2 epidemic in the UK, Hampshire Hospitals NHS Foundation Trust (HHFT) rapidly J o u r n a l P r e -p r o o f validated a novel RT-LAMP assay for SARS-CoV-2 RNA detection from nasopharyngeal/oropharyngeal swabs either directly, or following RNA extraction 17 . For direct detection of SARS-CoV-2 RNA from swabs, diluting the viral transport media 1 in 20 in nuclease free water (NFW) overcame inhibition.

When this sample preparation method was trialed on paired swab and saliva samples, inhibition was still evident for SARS-CoV-2 RNA detection from saliva. Herein we describe the further development of a simple preparation method for direct detection of SARS-CoV-2 RNA within saliva samples using Direct RT-LAMP.

Optimisation of the sample preparation method was initially performed using (i) spiked saliva, in which a pool of five SARS-CoV-2 negative saliva samples (University Hospital Southampton [UHS] staff) were spiked with whole beta-propriolactone inactivated virus (SARS-CoV-2 at ~1x10 5 TCID 50 /ml), (ii) three SARS-CoV-2 positive saliva samples collected from COVID-19 symptomatic patients at HHFT (n = 1) and UHS (n = 2) (confirmed SARS-CoV-2 positive in nasopharyngeal samples by rRT-PCR) and (iii) a pool of fifteen SARS-CoV-2 negative saliva samples (UHS).

To further refine optimum sample preparation methods, a rRT-PCR characterised panel of SARS-CoV-2 positives collected at HHFT (n = 5) and service evaluation studies from Southampton (n = 10) was used, alongside negative saliva samples from HHFT (n = 5) and healthcare and University staff in Southampton (n = 3,097). Analytical sensitivity was determined using a titration of a synthetic DNA fragment containing the SARS-CoV-2 RT-LAMP target in nuclease free water (Integrated DNA Technologies, Coralville, United States). Analytical specificity was determined using the NATtrol™ Respiratory Verification Panel 2 (ZeptoMetrix Corporation, New York, United States). All saliva was collected into a 10 ml universal container, with UHS saliva collection and analysis conducted with The saliva samples processed at the Animal and Plant Health Agency (APHA) were extracted using the MagMAX™CORE Nucleic acid purification kit (Thermofisher). 200 µl sample was added to 700 µl prepared lysis solution. Samples were inactivated for 10 minutes at room temperature before automated RNA extraction using a KingfisherFlex (Thermofisher). RNA was eluted in 90 µl NFW and tested using the E gene RT-PCR as described previously 18 using the AgPath-ID™ PCR kit (Thermofisher).

Samples were run on an Aria qPCR Cycler (Agilent) and results analysed using the Agilent AriaMX 1. ). An exponential increase in fluorescence (ΔF) indicated a positive reaction, which was quantified by the time to positivity (Tp). To confirm amplicon specificity, an anneal curve was performed: RT-LAMP products were heated to 98°C for 1 min, then cooled to 80°C decreasing the temperature by 0.05°C/s. Genie® embedded software was utilised to analyse results. (Figure 1 ). Using a synthetic DNA template spiked into saliva, the detection limit for these three protocols gave consistent results with a previous publication 17 , with a detection limit of between 1x10 1 and 1x10 2 copies / µl of sample determined (data not shown).

To evaluate diagnostic and analytical specificity a single protocol was selected (1:1 in Mucolyse TM , 1 in This study describes the rapid optimisation of a method for direct detection of SARS-CoV-2 RNA within saliva samples using RT-LAMP, without the need for RNA extraction. We show for the first time an optimised sample preparation method for SARS-CoV-2 RNA detection within crude saliva samples.

Using this approach, SARS-CoV-2 RNA was reliably detected from positive samples in duplicates over a wide range of dilutions, successfully overcoming matrix inhibition and/or matrix protection of viral capsid nucleic acid release (observed in the samples that did not receive this protocol). Importantly, using this method, no amplification was detected in negative pooled saliva or against other respiratory pathogens, confirming the specificity of this approach. Preliminary analysis of this kit was performed at APHA in triplicate on the ten SARS-CoV-2 positive saliva samples from service evaluation studies in Southampton and compared to rRT-PCR results using the E gene rRT-PCR as described above 18 . Results were in agreement with this study, with all triplicates positive for all samples (Supplement 1), however, further work is required to validate this new kit format.

Studies in macaque monkeys demonstrated that salivary glands are the first site to be infected by SARS-CoV infection 19 and several groups have reported high sensitivity and specificity of rRT-PCR on saliva for SARS-CoV-2 in COVID-19 patients 20, 21 . As such, population screening of saliva could be an effective strategy to detect individuals who are infectious (pre-symptomatic, symptomatic or asymptomatic). There is also evidence that SARS-CoV-2 may be present in saliva during the recovery phase, after upper respiratory samples have become negative 22 , making saliva an attractive sample for prolonged identification of SARS-CoV-2 from infectious individuals 7 .

These findings support saliva as a reliable sample in which to detect SARS-CoV-2 RNA. Using saliva collected in a simple container, we present a rapid diagnostic solution based on samples that can be collected at home or in non-healthcare settings. This approach overcomes the requirement for, and validation of, different swabs and the bottleneck observed in obtaining access to extraction platforms and reagents for rRT-PCR testing. Contributing to disease mitigation management, this opens the possibility of rapid public health testing to determine virus circulation through regular populationscale SARS-CoV-2 testing at relatively low cost, combined with isolation and contact tracing. 

Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults

Universal weekly testing as the UK COVID-19 lockdown exit strategy

Rapid-inexpensive-home-testing-for-covid-19-may-get-us-out-of-this-messbefore-a-vaccine

Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases

Rapid Salivary Test suitable for a mass screening program to detect SARS-CoV-2: A diagnostic accuracy study

Fielddeployable, rapid diagnostic testing of saliva samples for SARS-CoV-2. MedRxiv

A Review of Salivary Diagnostics and Its Potential Implication in Detection of Covid-19

Simply saliva: stability of SARS-CoV-2 detection negates the need for expensive collection devices

Loop-mediated isothermal amplification of DNA

Robustness of a loop-mediated isothermal amplification reaction for diagnostic applications

Development of a reverse transcription loop-mediated isothermal amplification assay for the detection of vesicular stomatitis New Jersey virus: Use of rapid molecular assays to differentiate between vesicular disease viruses

The development of two field-ready reverse transcription loop-mediated isothermal amplification assays for the rapid detection of Seneca Valley virus 1

Rapid and visual detection of 2019 novel coronavirus (SARS-CoV-2) by a reverse transcription loop-mediated isothermal amplification assay

Validation of a Loop-Mediated Isothermal Amplification Assay for Rapid Diagnosis of Invasive Pneumococcal Disease

A highly effective reverse-transcription loop-mediated isothermal amplification (RT-LAMP) assay for the rapid detection of SARS-CoV-2 infection

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Epithelial Cells Lining Salivary Gland Ducts Are Early Target Cells of Severe Acute Respiratory Syndrome Coronavirus Infection in the Upper Respiratory Tracts of Rhesus Macaques

Viral dynamics of SARS-CoV-2 in saliva from infected patients

Saliva is a reliable tool to detect SARS-CoV-2

Two cases of COVID-19 with positive salivary and negative pharyngeal or respiratory swabs at hospital discharge: a rising concern

J o u r n a l P r e -p r o o f Tp: Time to positivity (minutes:seconds). rRT-PCR was performed in duplicates on samples following a 1:20 dilution using an rRT-PCR assay as described previously 18 .